Summary
Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products. It undertakes the development, manufacture and marketing of medical products, which assist healthcare professionals and their patients in the treatment of end-stage renal diseases. Its portfolio include a comprehensive range of home, acute and in-center dialysis solutions, sterile IV solutions, infusion systems, parenteral nutrition, biosurgery products and anesthetics, and pharmacy automation, software and services. The products find application in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers and clinics. The company distributes its products through its own direct sales force; independent distributors, drug wholesalers acting as sales agents and specialty pharmacies or other alternate site providers. It has wide spread operations in the Americas, Middle East, Africa, Europe and Asia Pacific. Baxter is headquartered in Deerfield, Illinois, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Baxter International Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Baxter International Inc Company Overview 6
Baxter International Inc Company Snapshot 6
Baxter International Inc Pipeline Products and Ongoing Clinical Trials Overview 6
Baxter International Inc – Pipeline Analysis Overview 9
Business Description 9
Baxter International Inc - Key Facts 9
Baxter International Inc - Major Products and Services 10
Baxter International Inc Pipeline Products by Development Stage 13
Baxter International Inc Ongoing Clinical Trials by Trial Status 16
Baxter International Inc Pipeline Products Overview 18
Artis Dialysis System 18
Artis Dialysis System Product Overview 18
Artis Dialysis System Clinical Trial 19
DurADAPT Bioimplant 20
DurADAPT Bioimplant Product Overview 20
ENFit Enteral Syringe 21
ENFit Enteral Syringe Product Overview 21
Hemopatch 22
Hemopatch Product Overview 22
Hemopatch Clinical Trial 23
INDUCTIGRAFT 25
INDUCTIGRAFT Product Overview 25
Infusion Pump 26
Infusion Pump Product Overview 26
Next - Gen AK98 HD System 27
Next - Gen AK98 HD System Product Overview 27
Next Gen ICHD Monitor 28
Next Gen ICHD Monitor Product Overview 28
Non PVC CAPD 29
Non PVC CAPD Product Overview 29
Non-DEHP Sets 30
Non-DEHP Sets Product Overview 30
Ovart 3D Biodegradable Matrix 31
Ovart 3D Biodegradable Matrix Product Overview 31
Prismaflex Integrated With Gas Exchange Technology 32
Prismaflex Integrated With Gas Exchange Technology Product Overview 32
PrisMAX V1 33
PrisMAX V1 Product Overview 33
PRISMAX V2 34
PRISMAX V2 Product Overview 34
ProMaxx Microsphere 35
ProMaxx Microsphere Product Overview 35
SepXiris 36
SepXiris Product Overview 36
Sharesource Connect 37
Sharesource Connect Product Overview 37
Synthetic Bone Graft - Orthopaedic 38
Synthetic Bone Graft - Orthopaedic Product Overview 38
Synthetic Bone Graft - Spinal 39
Synthetic Bone Graft - Spinal Product Overview 39
Theralite 40
Theralite Product Overview 40
THERANOVA Dialyser 41
THERANOVA Dialyser Product Overview 41
THERANOVA Dialyser 42
THERANOVA Dialyser Product Overview 42
Tisseel Dura 43
Tisseel Dura Product Overview 43
URINFO 3000 44
URINFO 3000 Product Overview 44
Veritas - Cardiac Application 45
Veritas - Cardiac Application Product Overview 45
VIVIA Hemodialysis System 46
VIVIA Hemodialysis System Product Overview 46
VIVIA Hemodialysis System Clinical Trial 47
Baxter International Inc - Key Competitors 48
Baxter International Inc - Key Employees 49
Baxter International Inc - Key Employee Biographies 50
Baxter International Inc - Locations And Subsidiaries 51
Head Office 51
Other Locations & Subsidiaries 51
Affiliate 57
Joint Venture 57
Recent Developments 58
Baxter International Inc, Recent Developments 58
Apr 03, 2017: Baxter Unveils Design Enhancement to TISSEEL Hemostatic Agent at AORN Meeting 58
Apr 03, 2017: Baxter Unveils Design Enhancement to FLOSEAL Hemostatic Agent at AORN Meeting 58
Mar 14, 2017: New Data Indicates Use of Baxter’s FLOSEAL in Cardiac and Spinal Surgeries May Be Associated with Lower Hospital Costs 59
Feb 16, 2017: Baxter Debuts Enteral Nutrition ENFit Syringe and Accesory Line During Clinical Nutrition Week 2017 59
Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board 60
Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results 61
Dec 05, 2016: Baxter Introduces New Safety Management System and Software Updates for Sigma Spectrum Infusion System at ASHP Meeting 62
Nov 22, 2016: Baxter Presented Exploratory Research on the Removal of Inflammation-Related Molecules During Extracorporeal Blood Purification Therapy 63
Nov 21, 2016: New Data Presented at ASN Kidney Week Spotlight Baxter's SHARESOURCE Telehealth Platform and AMIA APD System in Supporting More Efficient Home Dialysis Care 64
Nov 17, 2016: Baxter to Present 24 Abstracts at ASN Kidney Week 2016 Focused on Elevating the Standard of Care For Dialysis Patients Globally 64
Appendix 66
Methodology 66
About GlobalData 68
Contact Us 68
Disclaimer 68
List of Tables
Baxter International Inc Pipeline Products and Ongoing Clinical Trials Overview 6
Baxter International Inc Pipeline Products by Equipment Type 7
Baxter International Inc Pipeline Products by Indication 8
Baxter International Inc Ongoing Clinical Trials by Trial Status 8
Baxter International Inc, Key Facts 9
Baxter International Inc, Major Products and Services 10
Baxter International Inc Number of Pipeline Products by Development Stage 13
Baxter International Inc Pipeline Products Summary by Development Stage 14
Baxter International Inc Ongoing Clinical Trials by Trial Status 16
Baxter International Inc Ongoing Clinical Trials Summary 17
Artis Dialysis System - Product Status 18
Artis Dialysis System - Product Description 18
Artis Dialysis System - Automated Setting of Individualized Sodium Technology (ASIST) - Proof of Principle Study 19
DurADAPT Bioimplant - Product Status 20
DurADAPT Bioimplant - Product Description 20
ENFit Enteral Syringe - Product Status 21
ENFit Enteral Syringe - Product Description 21
Hemopatch - Product Status 22
Hemopatch - Product Description 22
Hemopatch - A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures on High Risk Population for Prolonged Air Leak (more than 5 Days - PAL) 23
Hemopatch - A Prospective Randomized Trial of Hemopatch Versus No Hemopatch for the Intraoperative Hemostasis During Deceased Donor Renal Transplant 23
Hemopatch - Phase III, Randomized, Unblinded, Controlled Clinical Trial for Evaluating the Effectiveness of the use of the New Hemostatic Patch Hemopatch in Patients undergoing Surgical Liver Resection 23
Hemopatch - Prospective Randomized Clinical Trial to Prevent Air Leaks After Lung Resection with Hemopatch Sealing Hemostat: SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial 24
Hemopatch - Prospective, Multicenter, Open-label, Randomized, Phase III Clinical Trial of Prevention of Prolonged Air Leak after Lung Resection in High-risk Patients, Applying HEMOPATCH 24
INDUCTIGRAFT - Product Status 25
INDUCTIGRAFT - Product Description 25
Infusion Pump - Product Status 26
Infusion Pump - Product Description 26
Next - Gen AK98 HD System - Product Status 27
Next - Gen AK98 HD System - Product Description 27
Next Gen ICHD Monitor - Product Status 28
Next Gen ICHD Monitor - Product Description 28
Non PVC CAPD - Product Status 29
Non PVC CAPD - Product Description 29
Non-DEHP Sets - Product Status 30
Non-DEHP Sets - Product Description 30
Ovart 3D Biodegradable Matrix - Product Status 31
Ovart 3D Biodegradable Matrix - Product Description 31
Prismaflex Integrated With Gas Exchange Technology - Product Status 32
Prismaflex Integrated With Gas Exchange Technology - Product Description 32
PrisMAX V1 - Product Status 33
PrisMAX V1 - Product Description 33
PRISMAX V2 - Product Status 34
PRISMAX V2 - Product Description 34
ProMaxx Microsphere - Product Status 35
ProMaxx Microsphere - Product Description 35
SepXiris - Product Status 36
SepXiris - Product Description 36
Sharesource Connect - Product Status 37
Sharesource Connect - Product Description 37
Synthetic Bone Graft - Orthopaedic - Product Status 38
Synthetic Bone Graft - Orthopaedic - Product Description 38
Synthetic Bone Graft - Spinal - Product Status 39
Synthetic Bone Graft - Spinal - Product Description 39
Theralite - Product Status 40
Theralite - Product Description 40
THERANOVA Dialyser - Product Status 41
THERANOVA Dialyser - Product Description 41
THERANOVA Dialyser - Product Status 42
THERANOVA Dialyser - Product Description 42
Tisseel Dura - Product Status 43
Tisseel Dura - Product Description 43
URINFO 3000 - Product Status 44
URINFO 3000 - Product Description 44
Veritas - Cardiac Application - Product Status 45
Veritas - Cardiac Application - Product Description 45
VIVIA Hemodialysis System - Product Status 46
VIVIA Hemodialysis System - Product Description 46
VIVIA Hemodialysis System - A Study of Sleep Patterns in Patients Performing Nocturnal Home Dialysis Utilizing the VIVIA System 47
VIVIA Hemodialysis System - U.S. Clinical Trial for VIVIA Investigational Home Hemodialysis System 47
Baxter International Inc, Key Employees 49
Baxter International Inc, Key Employee Biographies 50
Baxter International Inc, Other Locations 51
Baxter International Inc, Subsidiaries 51
Baxter International Inc, Affiliate 57
Baxter International Inc, Joint Venture 57
Glossary 67
List of Figures
Baxter International Inc Pipeline Products by Equipment Type 7
Baxter International Inc Pipeline Products by Development Stage 13
Baxter International Inc Ongoing Clinical Trials by Trial Status 16
